These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 33042264)

  • 1. Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma.
    Mani SKK; Yan B; Cui Z; Sun J; Utturkar S; Foca A; Fares N; Durantel D; Lanman N; Merle P; Kazemian M; Andrisani O
    Theranostics; 2020; 10(24):10957-10972. PubMed ID: 33042264
    [No Abstract]   [Full Text] [Related]  

  • 2. DDX5 deficiency drives non-canonical NF-κB activation and NRF2 expression, influencing sorafenib response and hepatocellular carcinoma progression.
    Li Z; Kim W; Utturkar S; Yan B; Lanman NA; Elzey BD; Kazemian M; Yeo Y; Andrisani O
    Cell Death Dis; 2024 Aug; 15(8):583. PubMed ID: 39122708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis.
    Zhang H; Xing Z; Mani SK; Bancel B; Durantel D; Zoulim F; Tran EJ; Merle P; Andrisani O
    Hepatology; 2016 Oct; 64(4):1033-48. PubMed ID: 27338022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes.
    Sun J; Wu G; Pastor F; Rahman N; Wang WH; Zhang Z; Merle P; Hui L; Salvetti A; Durantel D; Yang D; Andrisani O
    Gut; 2022 May; 71(5):991-1005. PubMed ID: 34021034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin-ferroptosis axis.
    Li Z; Caron de Fromentel C; Kim W; Wang WH; Sun J; Yan B; Utturkar S; Lanman NA; Elzey BD; Yeo Y; Zhang H; Kazemian M; Levrero M; Andrisani O
    Cell Death Dis; 2023 Nov; 14(11):786. PubMed ID: 38036507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
    Zhao H; Xie Z; Tang G; Wei S; Chen G
    J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytes.
    Chapus F; Giraud G; Huchon P; Rodà M; Grand X; Charre C; Goldsmith C; Roca Suarez AA; Martinez MG; Fresquet J; Diederichs A; Locatelli M; Polvèche H; Scholtès C; Chemin I; Hernandez Vargas H; Rivoire M; Bourgeois CF; Zoulim F; Testoni B
    J Hepatol; 2024 Oct; 81(4):609-620. PubMed ID: 38782119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC.
    Rana MA; Ijaz B; Daud M; Tariq S; Nadeem T; Husnain T
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):373-386. PubMed ID: 30377095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression.
    Sun T; Zhang J
    J Biochem; 2021 Dec; 170(5):663-673. PubMed ID: 34347084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.
    Studach LL; Menne S; Cairo S; Buendia MA; Hullinger RL; Lefrançois L; Merle P; Andrisani OM
    Hepatology; 2012 Oct; 56(4):1240-51. PubMed ID: 22505317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Virus DNA Polymerase Restrains Viral Replication Through the CREB1/HOXA Distal Transcript Antisense RNA Homeobox A13 Axis.
    Zhao X; Fan H; Chen X; Zhao X; Wang X; Feng Y; Liu M; Li S; Tang H
    Hepatology; 2021 Feb; 73(2):503-519. PubMed ID: 32314410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.
    Feng J; Yang G; Liu Y; Gao Y; Zhao M; Bu Y; Yuan H; Yuan Y; Yun H; Sun M; Gao H; Zhang S; Liu Z; Yin M; Song X; Miao Z; Lin Z; Zhang X
    Theranostics; 2019; 9(18):5227-5245. PubMed ID: 31410212
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.
    Chavalit T; Nimsamer P; Sirivassanametha K; Anuntakarun S; Saengchoowong S; Tangkijvanich P; Payungporn S
    Microrna; 2020; 9(3):232-239. PubMed ID: 31686644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
    Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J; Steel LF; Bouchard MJ
    World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
    Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
    Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
    Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant.
    Halgand B; Desterke C; Rivière L; Fallot G; Sebagh M; Calderaro J; Bioulac-Sage P; Neuveut C; Buendia MA; Samuel D; Féray C
    Hepatology; 2018 Jan; 67(1):86-96. PubMed ID: 28802063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
    Fan H; Cui Z; Zhang H; Mani SK; Diab A; Lefrancois L; Fares N; Merle P; Andrisani O
    Oncogene; 2017 Apr; 36(17):2435-2445. PubMed ID: 27797380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.